Microenvironment-Responsive Theranostic Platform - Autocatalytic Regenerative Systems.
Abstract
Annotation: The paper discusses the non-obvious mechanisms of copper-based nano-MOF with bidentate ligands in an innovative therapeutic strategy for the treatment of gouty arthritis based on the sequential use of two precision systems "Two-phase nano-MOF/DES platform for trigger destruction of monourates and synergetic regeneration of the articular matrix: from DFT modeling to in-vivo validation". The first phase is copper-based nano-MOF with bidentate ligands (5-oxoproline, gallic acid, nicotinamide), which has trigger uricase activity and as a synthetic analogue of superoxide dismutase (Cu,Zn-SOD) or galactose oxidase. В работе рассмотрены неочевидные механизмы работы нано-MOF на основе меди с бидентатными лигандами в инновационной терапевтической стратегии лечения подагрического артрита, основанном на последовательном применении двух прецизионных систем «Two-phase nano-MOF/DES platform for trigger destruction of monourates and synergetic regeneration of the articular matrix: from DFT modeling to in-vivo validation». Первая фаза — нано-MOF на основе меди с бидентатными лигандами (5-оксопролин ,галловая кислота,никотинамид ), обладающий триггерной уриказной активностью и как синтетический аналог супероксиддисмутазы (Cu,Zn-SOD) или галактозооксидазы.
Fields of Study & Subjects
Osteoarthritis Treatment and Mechanisms
Gout
Hyperuricemia
Uric Acid
Bone Tissue Engineering Materials
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 4 January 2026